These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 18971014)

  • 61. [Hyperuricemia].
    Gröbner W; Zöllner N
    Internist (Berl); 1995 Dec; 36(12):1207-21. PubMed ID: 8567232
    [No Abstract]   [Full Text] [Related]  

  • 62. [Hyperuricemia due to renal failure, autosomal dominant polycystic kidney disease and lead nephropathy].
    Hosoya T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():294-8. PubMed ID: 12629734
    [No Abstract]   [Full Text] [Related]  

  • 63. Consider gout in patients with risk factors, regardless of age.
    Olaniyi-Leyimu BY
    Am Fam Physician; 2008 Jul; 78(2):176. PubMed ID: 18697500
    [No Abstract]   [Full Text] [Related]  

  • 64. [Severity of a female gout course].
    Barskova VG; Nasonova VA; Iakunina IA; Il'inykh EV; Kudaeva FM
    Ter Arkh; 2005; 77(5):58-62. PubMed ID: 15989006
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Practical strategies for lifestyle modification in people with hyperuricemia and gout treatment through diet, physical activity, and reduced alcohol consumption].
    Mineo I; Kamiya H; Tsukuda A
    Nihon Rinsho; 2008 Apr; 66(4):736-41. PubMed ID: 18409524
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gout and related morbid conditions: pharmacological and SPA therapy.
    Petraccia L; Fraioli A; Liberati G; Lopalco M; Grassi M
    Minerva Med; 2008 Apr; 99(2):203-12. PubMed ID: 18431328
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical manifestations and diagnosis of gout.
    Perez-Ruiz F; Castillo E; Chinchilla SP; Herrero-Beites AM
    Rheum Dis Clin North Am; 2014 May; 40(2):193-206. PubMed ID: 24703343
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.
    Bardin T; Richette P
    BMC Med; 2017 Jul; 15(1):123. PubMed ID: 28669352
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tophus gout and chronic kidney disease in a young female patient: report of familial juvenile hyperuricemic nephropathy in three generations of the same family.
    Medeiros MM; Silva GB; Daher EF
    Rheumatol Int; 2012 Nov; 32(11):3687-90. PubMed ID: 21909621
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An initial presentation of polyarticular gout with spinal involvement.
    Fontenot A; Harris P; Macasa A; Menon Y; Quinet R
    J Clin Rheumatol; 2008 Jun; 14(3):188-9. PubMed ID: 18525444
    [No Abstract]   [Full Text] [Related]  

  • 71. [When to treat asymptomatic hyperuricemia?].
    Chalès G
    Rev Prat; 2015 May; 65(5):672. PubMed ID: 26165107
    [No Abstract]   [Full Text] [Related]  

  • 72. Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room?
    Abhishek A; Doherty M
    Arthritis Res Ther; 2017 Aug; 19(1):184. PubMed ID: 28797283
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Juvenile gout in Taiwan associated with family history and overweight.
    Chen SY; Shen ML
    J Rheumatol; 2007 Nov; 34(11):2308-11. PubMed ID: 17937457
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Strengthen and standardize the diagnosis and treatment of hyperuricemia in kidney diseases].
    Feng Z; Chen XM
    Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(25):1921-1922. PubMed ID: 28693068
    [No Abstract]   [Full Text] [Related]  

  • 75. Long-term medical management of the liver transplant recipient: what the primary care physician needs to know.
    Singh S; Watt KD
    Mayo Clin Proc; 2012 Aug; 87(8):779-90. PubMed ID: 22763347
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Factors associated with recurrent hospital admissions for gout: a case-control study.
    Hutton I; Gamble G; Gow P; Dalbeth N
    J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements.
    Li Q; Li X; Kwong JS; Chen H; Sun X; Tian H; Li S
    BMJ Open; 2017 Jun; 7(6):e014928. PubMed ID: 28645962
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diagnosis of gout.
    Schlesinger N
    Minerva Med; 2007 Dec; 98(6):759-67. PubMed ID: 18299687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Validation of claims-based algorithms for gout flares.
    MacFarlane LA; Liu CC; Solomon DH; Kim SC
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):820-6. PubMed ID: 27230083
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hyperuricemia and tissue monourate deposits: prospective therapeutic considerations.
    Perez-Ruiz F; Punzi L
    Eur Rev Med Pharmacol Sci; 2015; 19(9):1549-52. PubMed ID: 26004589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.